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Background: Type 1 autoimmune pancreatitis (AIP) often accompanies various systematic disorders such as
sclerosing cholangitis, sialoadenitis, retroperitoneal fibrosis, interstitial pneumonitis and nephritis. Although rarely
reported in acute pancreatitis, colonic stenosis is an uncommon complication in cases with AIP.
Case presentation: A 69-year-old Japanese man complained of abdominal pain and continuous diarrhea, resistant
to intake of antimuscarinic and probiotic agents. A colonoscopy demonstrated a stenosis at the splenic flexure.
Computed tomography revealed a focal enlargement of the pancreatic tail with a capsule-like rim, contacting with
the descending colon. Endoscopic retrograde pancreatography (ERP) was unable to visualize the main pancreatic
duct (MPD) at the pancreatic tail, despite a full contrast injection. A high serum IgG4 level (1060 mg/dL) and exclusion
of pancreatic cancer by endoscopic ultrasound guided-fine needle aspiration suggested AIP, but did not fulfill the
diagnostic criteria, and steroid therapy was initiated. One month after starting steroid intake, pancreatic swelling was
minimized and the MPD was visualized by ERP, fulfilling the international consensus diagnostic criteria (ICDC) of AIP.
Colonic stenosis was relieved and the patient’s symptoms disappeared.
Conclusion: The present case is the first report of AIP developing colonic stenosis by the inflammatory infiltration.
In this case, steroid therapy was effective for the diagnosis and treatment of pancreatic mass involving the
descending colon.
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Cases of autoimmune pancreatitis (AIP) mostly manifest
as complaints of abdominal pain, jaundice, dullness,
weight loss, development or worsening of diabetes melli-
tus, and symptoms associated with other organ involve-
ments (OOI). Type1 AIP, characterized by narrowing of
the main pancreatic duct (MPD) by lymph plasmacytic
sclerosing pancreatitis and high levels of serum IgG4,
often accompanies OOI such as the lachrymal and saliv-
ary glands, lung, biliary tract, liver, kidney, retroperito-
neum, urinary tract, and prostate [1,2]. This report
presents a case of AIP accompanied by stenosis of the
MPD and of the descending colon.* Correspondence: h.matsubayashi@scchr.jp
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A 69-year-old Japanese man suffered from intermittent
abdominal pain and repetitive diarrhea for a month,
and visited the nearest hospital. He had habits of drink-
ing alcohol and smoking. His past history included only
prostate hypertrophy and his family history was unremark-
able. A colonoscopy (Figure 1A) revealed mucosal erosion
accompanied with converging folds and luminal stenosis
at the splenic flexure. Biopsy tissue obtained from the ero-
sion showed the histology of non-specific colitis without
neoplastic cells [IgG4-positive cells: 2 cells/high power
field (HPF)]. Computed tomography (CT) (Figure 2A)
revealed a focally enlarged pancreatic tail with het-
erogeneous contrast enhancement. The tail of the pan-
creas showed soft tissue proliferation surrounding the
pancreas that appeared to adhere to the descendingentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Colonoscopic views at the splenic flexure before (A) and after (B) steroid therapy. The erosion associated with a converging fold
and luminal stenosis (A). Healed erosion with an indistinct mucosal vascular pattern (B).
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contrast enema (Figure 3) revealed an irregularly nar-
rowed segment of the large bowel at the splenic flexure.
His symptoms had been resistant to any medications
(e.g., tiquizium bromide, camostat mesilate, or miyarisan)
and he had lost 7 kg of weight during the previous two
months. Pancreatic tail cancer invading to the colon had
to be ruled out, so the patient was referred to our hos-
pital. Blood tests showed an increasing level of serum
amylase (703 U/L) and c reactive protein (3.0 mg/dL).
Serum tumor markers (carcinoembryonic antigen and
carbohydrate antigen 19–9) and HbA1c were within the
normal range, but serum IgG (2661 mg/dL: ≤1700 mg/dL),
IgG4 (1060 mg/dL, normal: ≤105 mg/dL), and IgE
(317 IU/mL, normal: ≤173 IU/mL) were all elevated. Anti-
nuclear antibody and rheumatoid arthritis particle agglu-
tination were also increased in the serum (positive at ×80Figure 2 Enhanced computed tomography showing an enlarged pan
pancreas, adhesive to the descending colon (large arrow), with a capsule-like
Minimized pancreatic swelling and decreased effusion (B).and ×160 dilution, respectively). Endoscopic ultrasound
(EUS) showed mosaic high echoic foci within the low-
echoic, swollen pancreatic tail, with a capsule-like rim
structure (Figure 4). Endoscopic retrograde cholangiog-
raphy (ERC) showed diffusely thin intrahepatic bile ducts
(Figure 5A). Pancreatography demonstrated a stenosis
of the MPD despite the high pressure of contrast in-
jection (Figure 5B) [3]. Intraductal ultrasound of the
bile duct showed no remarkable findings [4]. Biopsied
tissues from the bile duct and major papilla were non-
neoplastic and showed only a scattering of IgG4-positive
cells (3 cells/HPF). On the following day, the patient
complained of mild left hypochondralgia and had a high
level of serum amylase (667 U/L), suggesting a develop-
ment of mild post-ERCP pancreatitis. Pancreatic cancer
was excluded by an EUS-guided fine needle aspiration
biopsy (FNAB) [5] performed from the gastric body usingcreatic tail, before (A) and after (B) steroid initiation. A swollen
rim (arrow head) and effusion (small arrow) around the left kidney (A).
Figure 3 Contrast enema showing an irregular stenosis of the
colon at the splenic flexure.
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The obtained specimens showed neither cancer tissue
nor IgG4-positive plasma cells. 18 F-fluorodeoxyglucose
positron emission tomography (FDG-PET) demonstrated
abnormal uptakes at the pancreatic tail (SUVmax: 7.2),Figure 4 Endoscopic ultrasonographic view showing the
low-echoic, enlarged pancreatic tail with a marginal capsule-like
rim (arrowhead).and at the lymph nodes of mediastinal and inguinal re-
gion (Figure 6). No OOIs suggestive of AIP, such as
biliary stricture, retroperitoneal fibrosis, enlargement of
salivary or lachrymal glands, were apparent in any of the
image examinations. A rapid steroid trial was initiated
with 30 mg/day of prednisolone based on the suspected
diagnosis of AIP and the continued need to exclude pan-
creatic cancer, since the imaging findings did not fulfill
any of the diagnostic criteria for AIP [1]. A steroid
response was not obvious at two weeks after steroid initi-
ation, but improvement in the pancreatic tail enlarge-
ment and peripancreatic effusion was recognized by
abdominal ultrasonography (US) and CT at one month
after steroid initiation (Figure 2B). The second look
ERCP demonstrated a non-remarkable change in the bil-
iary tract but obvious improvement of stenosis of the
MPD (Figure 5C). The following CF (Figure 1B) con-
firmed the wide opening of the colon. This steroid re-
sponse satisfied the international consensus diagnostic
criteria (ICDC) [2], but did not fulfill the Japanese criteria
(2011) [1]. The patient’s symptoms disappeared and his
subsequent progress was uneventful.
Discussion
The current case showed an increasing level of serum
IgG4 and a colonic stenosis without evidence of inflam-
matory bowel disease; hence, it is thought to be a type1
rather than a type2 AIP. Colonic manifestation has sel-
dom been reported as a complication in cases of type1
AIP [1,2]. The initial ERP demonstrated a stenosis of
the MPD, but not a narrowing [3]. These findings con-
founded the diagnosis of current case as AIP, and cor-
ticosteroid administration played important roles both in
diagnosis and in therapeutic aspects.
The diagnostic criteria of AIP define the pancreato-
graphic finding as a long or segmental “narrowing” of
the MPD [1-3], but not as a stenosis or obstruction. The
finding upstream of the stricture that is described in the
ICDC [1,2] can only be visualized by high pressure injec-
tion of the contrast, but this makes post-ERCP pancrea-
titis a concern, especially in cases with a pancreatic tail
lesion. Actually, in the current case, the initial pancrea-
tography demonstrated a stenosis of the MPD even with
a considerably high pressure of contrast injection; thus,
pancreatography may worsen the pancreatitis. Hence,
current case did not meet the diagnostic criteria of
ICDC before steroid therapy [1,2].
The lack of definitive histological evidence and typical
OOIs meant that this case did not meet the any of diag-
nostic criteria of AIP, until the steroid trial. Usually a
steroid response should be determined over a short
interval [1] and we anticipated a response visible by US
but failed to confirm this within two weeks. Our experi-
ence using abdominal US is that an obvious downsizing
Figure 5 Endoscopic retrograde cholangiopancreatography. Thin structure of the intrahepatic bile duct (A). Pancreatography showing a
stenosis of the main pancreatic duct before steroid therapy (B). Reopening of the main pancreatic duct after the steroid initiation (C).
Figure 6 18 F-fluorodeoxyglucose positron emission tomography
showing abnormal uptake of 18 F-fluorodeoxyglucose at the
pancreatic tail (large arrow), as well as at the lymph nodes of the
mediastinum (arrowhead) and inguinalis (small arrow).
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two weeks of steroid administration [6]. However, evalu-
ation of the margin of the pancreatic tail lesion with sur-
rounding effusion may be difficult using US. In these
atypical cases, confirming the reopening of the stenotic
MPD or reexamination by EUS-FNAB is likely to be
necessary, as in current case. The steroid response ul-
timately seen in our case meant that it met the criteria
of the ICDC [2], but not Japanese criteria (2011), which
requires “irregular narrowing of the MPD” in any set of
diagnostic criteria when a definitive pathological diagno-
sis is lacking [1]. Future revision of the criteria should
take the present findings into consideration.
Colonic involvement has been very infrequently re-
ported in a small number of cases with conventional
acute pancreatitis (<50 cases listed by PubMed keyword
survey), and mostly at the splenic flexure as in the
present case. These occurrences were confused with a
carcinoma based on endoscopic, radiologic, or laparo-
tomic findings [7]. A colonic stenosis is thought to arise
either as a consequence of ischemia and necrosis due to
active pancreatitis or because of compression due to a
pancreatic pseudocyst [8,9]. Colonic obstruction arising
during the acute phase of pancreatitis usually is spontan-
eously reversible, but operation is required in cases with
colonic necrosis or persistent intestinal obstruction.
Cases with severe necrosis sometimes develop adjacent
abscesses, perforations, or peritonitis [7] and cannot be
rescued even with surgery (6 out of 22 surgical cases,
reported by Aldridge et al. in 1989) [10]. In our case, ac-
cording to the clinical images (Figures 1, 2 and 3) and
biopsy obtained from the colonic erosion (low level of
IgG4-positive cells), the colonic stricture was supposed
to be secondary to the inflammation caused by AIP,
rather than the colonic manifestation of IgG4-related
systemic disorders. The level of the stricture fortunately
was not severe, but the colonic stenosis associated with
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patient’s symptoms necessitated intrinsic treatments.
In this patient, a pancreatic enzyme inhibitor and intes-
tinal regulators were not effective but the corticosteroid
worked well.
Conclusion
The current case with AIP was highly suggestive from
the viewpoints of colonic involvement and the lack of
visualization of the MPD. The steroid trial was effective
in both diagnosis and therapy in this case.
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